Literature DB >> 3476961

Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line.

D Spriggs, K Imamura, C Rodriguez, J Horiguchi, D W Kufe.   

Abstract

Tumor necrosis factor (TNF) is a polypeptide cytokine that is cytotoxic to some but not all tumor cells. The basis for resistance to the cytotoxic effects of this agent remains unclear. We have studied the development of TNF resistance in human ZR-75-1 breast carcinoma cells. ZR-75-1 cells have undetectable levels of TNF RNA and protein. However, TNF transcripts are transiently induced in these cells by exposure to recombinant human TNF. This induction of TNF RNA is associated with production of TNF-like protein in cell lysates and culture supernatants. Stable resistance to TNF-induced cytotoxicity develops when ZR-75-1 cells are exposed to increased concentrations of TNF. The TNF-resistant cells, designated ZR-75-1R, continuously express TNF transcripts and a TNF-like protein. Furthermore, ZR-75-1R cell supernatants contain cytotoxic activity that is abrogated by polyclonal antibody against TNF. The ZR-75-1R cells also possess TNF receptors that are occupied or down-regulated by the TNF-like protein. These findings thus suggest that (i) TNF induces TNF transcripts and production of a TNF-like protein in ZR-75-1 cells and (ii) resistance to TNF-induced cytotoxicity is associated with stable TNF expression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3476961      PMCID: PMC299119          DOI: 10.1073/pnas.84.18.6563

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Plating procedure for the enumeration of coliforms from dairy products.

Authors:  B Ray; M L Speck
Journal:  Appl Environ Microbiol       Date:  1978-04       Impact factor: 4.792

2.  Expression of the c-fms proto-oncogene during human monocytic differentiation.

Authors:  E Sariban; T Mitchell; D Kufe
Journal:  Nature       Date:  1985 Jul 4-10       Impact factor: 49.962

3.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  Cell cycle-specific effects of tumor necrosis factor.

Authors:  Z Darzynkiewicz; B Williamson; E A Carswell; L J Old
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

5.  Molecular cloning of the complementary DNA for human tumor necrosis factor.

Authors:  A M Wang; A A Creasey; M B Ladner; L S Lin; J Strickler; J N Van Arsdell; R Yamamoto; D F Mark
Journal:  Science       Date:  1985-04-12       Impact factor: 47.728

6.  Preparations of lymphotoxin induce resistance to their own cytotoxic effect.

Authors:  D Wallach
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

7.  Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.

Authors:  B D Williamson; E A Carswell; B Y Rubin; J S Prendergast; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

8.  Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor.

Authors:  T Shirai; H Yamaguchi; H Ito; C W Todd; R B Wallace
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

9.  Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein.

Authors:  T Hahn; L Toker; S Budilovsky; D Aderka; Z Eshhar; D Wallach
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  30 in total

1.  Cross-talk between receptor tyrosine kinase and tumor necrosis factor-α signaling networks regulates apoptosis but not proliferation.

Authors:  Elsa M Beyer; Gavin MacBeath
Journal:  Mol Cell Proteomics       Date:  2012-02-08       Impact factor: 5.911

2.  Tumor necrosis factor expression in human epithelial tumor cell lines.

Authors:  D R Spriggs; K Imamura; C Rodriguez; E Sariban; D W Kufe
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 3.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

4.  Interleukin 1 beta and phorbol ester induce tumour necrosis factor alpha production in a hepatic cell line (HepG2).

Authors:  S Frede; J Fandrey; W Jelkmann
Journal:  Pflugers Arch       Date:  1996-04       Impact factor: 3.657

Review 5.  Resistance of tumor cells to tumor necrosis factor.

Authors:  H M Shepard; G D Lewis
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

Review 6.  Tumour necrosis factor.

Authors:  S Malik; F R Balkwill
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-30

7.  Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin.

Authors:  G Mannori; D Santoro; L Carter; C Corless; R M Nelson; M P Bevilacqua
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

Review 8.  Are cellular adhesion molecules involved in the metastasis of breast cancer?

Authors:  M Maemura; R B Dickson
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization.

Authors:  S Beissert; M Bergholz; I Waase; G Lepsien; A Schauer; K Pfizenmaier; M Krönke
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Sensitivity to tumour necrosis factor-mediated cytolysis is unrelated to manganous superoxide dismutase messenger RNA levels among transformed mouse fibroblasts.

Authors:  J M Boss; S M Laster; L R Gooding
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.